Easier-To-Produce Room Temperature Covid Shot Shows Promise In Early Clinical Trials

Easier-To-Produce Room Temperature Covid Shot Shows Promise In Early Clinical Trials

Akston Biosciences protein-based shot was well-tolerated and provoked an immune response in all those receiving the higher dose tested, according to data from the company’s clinical trial.

Read More

Tags: No tags

Add a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.